Literature DB >> 11453923

Successful treatment of cutaneous Langerhans cell histiocytosis with low-dose methotrexate.

A E Steen1, K H Steen, R Bauer, T Bieber.   

Abstract

Langerhans cell histiocytosis (LCH) can be a difficult therapeutic problem. We present a 40-year-old woman with a 4-year history of LCH who was successfully treated with low-dose methotrexate (20 mg weekly).

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11453923     DOI： 10.1046/j.1365-2133.2001.04298.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


  12 in total

1.  Differentiating skin-limited and multisystem Langerhans cell histiocytosis.

Authors:  Stephen J Simko; Benjamin Garmezy; Harshal Abhyankar; Philip J Lupo; Rikhia Chakraborty; Karen Phaik Har Lim; Albert Shih; M John Hicks; Teresa S Wright; Moise L Levy; Kenneth L McClain; Carl E Allen
Journal:  J Pediatr       Date:  2014-10-21       Impact factor: 4.406

Review 2.  Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.

Authors:  Matthias Papo; Fleur Cohen-Aubart; Ludovic Trefond; Adeline Bauvois; Zahir Amoura; Jean-François Emile; Julien Haroche
Journal:  Curr Oncol Rep       Date:  2019-05-21       Impact factor: 5.075

3.  Ninety-year-old man with hypereosinophilia, lymphadenopathies and pruritus.

Authors:  José Guilherme Freitas; Ana Jorge; Daniel Rei; Joana Graça
Journal:  BMJ Case Rep       Date:  2018-01-10

Review 4.  Langerhans cell histiocytosis.

Authors:  Kevin Bradford Hoover; Daniel I Rosenthal; Henry Mankin
Journal:  Skeletal Radiol       Date:  2006-10-07       Impact factor: 2.128

5.  Photodynamic therapy for multi-resistant cutaneous Langerhans cell histiocytosis.

Authors:  Valérie Failla; Odile Wauters; Marie Caucanas; Nazli Nikkels-Tassoudji; Arjen F Nikkels
Journal:  Rare Tumors       Date:  2010-06-30

6.  Topical Imiquimod for the Treatment of Relapsed Cutaneous Langerhans Cell Histiocytosis after Chemotherapy in an Elderly Patient.

Authors:  Shinsaku Imashuku; Miyako Kobayashi; Yoichi Nishii; Keisuke Nishimura
Journal:  Case Rep Dermatol Med       Date:  2018-01-03

7.  Comparison between low-dose chemotherapy and surgery for the treatment of extremity-associated solitary bone lesions in children with Langerhans cell histiocytosis in South China: A case-control study.

Authors:  Hongyi Li; Xianbiao Xie; Junqiang Yin; Jian Tu; Xiaoshuai Wang; Weihai Liu; Jiajun Zhang; Hongbo Li; Changye Zou; Yongqian Wang; Jingnan Shen; Gang Huang
Journal:  J Bone Oncol       Date:  2018-02-15       Impact factor: 4.072

Review 8.  Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net.

Authors:  Michael Girschikofsky; Maurizio Arico; Diego Castillo; Anthony Chu; Claus Doberauer; Joachim Fichter; Julien Haroche; Gregory A Kaltsas; Polyzois Makras; Angelo V Marzano; Mathilde de Menthon; Oliver Micke; Emanuela Passoni; Heinrich M Seegenschmiedt; Abdellatif Tazi; Kenneth L McClain
Journal:  Orphanet J Rare Dis       Date:  2013-05-14       Impact factor: 4.123

9.  Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years.

Authors:  Riccardo Haupt; Milen Minkov; Itziar Astigarraga; Eva Schäfer; Vasanta Nanduri; Rima Jubran; R Maarten Egeler; Gritta Janka; Dragan Micic; Carlos Rodriguez-Galindo; Stefaan Van Gool; Johannes Visser; Sheila Weitzman; Jean Donadieu
Journal:  Pediatr Blood Cancer       Date:  2012-10-25       Impact factor: 3.167

10.  Clinical and radiological responses to oral methotrexate alone or in combination with other agents in Erdheim-Chester disease.

Authors:  Gaurav Goyal; Mithun V Shah; Timothy G Call; C Christopher Hook; William J Hogan; Ronald S Go
Journal:  Blood Cancer J       Date:  2017-12-15       Impact factor: 11.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.